Latest news with #Claritev
Yahoo
3 days ago
- Business
- Yahoo
Claritev's (NYSE:CTEV) investors will be pleased with their splendid 109% return over the last year
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really flourishing, you can make more than 100%. For example, the Claritev Corporation (NYSE:CTEV) share price had more than doubled in just one year - up 109%. It's also good to see the share price up 94% over the last quarter. On the other hand, longer term shareholders have had a tougher run, with the stock falling 82% in three years. Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Claritev isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. Some companies are willing to postpone profitability to grow revenue faster, but in that case one would hope for good top-line growth to make up for the lack of earnings. In the last year Claritev saw its revenue shrink by 3.3%. We're a little surprised to see the share price pop 109% in the last year. It just goes to show the market doesn't always pay attention to the reported numbers. Of course, it could be that the market expected this revenue drop. The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers). It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. That said, we think earnings and revenue growth trends are even more important factors to consider. This free report showing analyst forecasts should help you form a view on Claritev We're pleased to report that Claritev shareholders have received a total shareholder return of 109% over one year. That certainly beats the loss of about 14% per year over the last half decade. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 3 warning signs for Claritev you should be aware of, and 1 of them makes us a bit uncomfortable. There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
29-05-2025
- Business
- Yahoo
Claritev Upgraded to Overweight at Piper Sandler with a $44 Price Target
Piper Sandler has upgraded Claritev Corporation (NYSE:CTEV) shares, impressed by the company's first quarter 2025 results. On May 28, the firm upgraded the stock to an Overweight from a Neutral. Additionally, it hiked the price target to $44 from $19. The significant price hike underscores expectations of stronger performance. A closeup of a computer screen with data-driven analytics and business solutions displayed. The adjustment follows the technology data and insights company delivering a 1.4% year-over-year decrease in revenue to $231.3 million in Q1. Amid the total revenue decrease, the Claritev Payment and Revenue Integrity segment posted a 9.7% year-over-year growth. In addition, Claritev reaffirmed its full-year revenue guidance, indicating a potential bounce back to growth. Additionally, Piper Sandler upgraded Claritev, impressed by the signing of a three-year contract renewal with ELV. Establishing commercial partnerships backed by a growing project pipeline is expected to address customer concentration risks. Piper Sandler has echoed the strategic moves, reiterating they position Claritev to meet its 2025 guidance and continue growing in 2026. Claritev also achieved significant milestones in the quarter. It inked a deal with Burjeel Holdings to enhance its revenue cycle management in the Middle East and North Africa. The partnership will also streamline the reimbursement process and reduce unnecessary denials, enabling workforce efficiency in business operations. Claritev Corporation provides data analytics and cost management solutions for the U.S. healthcare industry. Using data-driven insights, it helps reduce medical costs by detecting claim overcharges, optimizing reimbursements, and managing provider networks. Its payment integrity services eliminate unnecessary charges and recover underpaid premiums, while its decision science tools improve benefit plans, clinical outcomes, and cost efficiency. Claritev serves insurance companies, health plans, TPAs, and other claim adjudication entities. While we acknowledge the potential of Claritev Corporation (NYSE:CTEV) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CTEV and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-05-2025
- Business
- Yahoo
Claritev Upgraded to Overweight at Piper Sandler with a $44 Price Target
Piper Sandler has upgraded Claritev Corporation (NYSE:CTEV) shares, impressed by the company's first quarter 2025 results. On May 28, the firm upgraded the stock to an Overweight from a Neutral. Additionally, it hiked the price target to $44 from $19. The significant price hike underscores expectations of stronger performance. A closeup of a computer screen with data-driven analytics and business solutions displayed. The adjustment follows the technology data and insights company delivering a 1.4% year-over-year decrease in revenue to $231.3 million in Q1. Amid the total revenue decrease, the Claritev Payment and Revenue Integrity segment posted a 9.7% year-over-year growth. In addition, Claritev reaffirmed its full-year revenue guidance, indicating a potential bounce back to growth. Additionally, Piper Sandler upgraded Claritev, impressed by the signing of a three-year contract renewal with ELV. Establishing commercial partnerships backed by a growing project pipeline is expected to address customer concentration risks. Piper Sandler has echoed the strategic moves, reiterating they position Claritev to meet its 2025 guidance and continue growing in 2026. Claritev also achieved significant milestones in the quarter. It inked a deal with Burjeel Holdings to enhance its revenue cycle management in the Middle East and North Africa. The partnership will also streamline the reimbursement process and reduce unnecessary denials, enabling workforce efficiency in business operations. Claritev Corporation provides data analytics and cost management solutions for the U.S. healthcare industry. Using data-driven insights, it helps reduce medical costs by detecting claim overcharges, optimizing reimbursements, and managing provider networks. Its payment integrity services eliminate unnecessary charges and recover underpaid premiums, while its decision science tools improve benefit plans, clinical outcomes, and cost efficiency. Claritev serves insurance companies, health plans, TPAs, and other claim adjudication entities. While we acknowledge the potential of Claritev Corporation (NYSE:CTEV) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CTEV and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Zawya
29-05-2025
- Business
- Zawya
Claritev appoints Mohamed Ramzy as SVP and General Manager, International to lead geographic expansion
Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US MCLEAN, Va. & ABU DHABI, United Arab Emirates -- (BUSINESS WIRE) -- Claritev Corporation ('Claritev') (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ('MENA') region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology solutions in MENA following the previously announced strategic collaboration with Burjeel Holdings and Claims Care Revenue Cycle Management. Mohamed Ramzy has been appointed Senior Vice President and General Manager, International, reporting directly to Chairman, CEO and President, Travis Dalton. Ramzy will sit on the Executive Leadership Team and oversee strategy, operations and business development across MENA. He brings nearly two decades of healthcare technology experience, most recently as Country General Manager at Oracle Health, where he led operations across the Arabian Gulf and Africa. His earlier roles at Oracle Health (formerly Cerner) included launching regional branches and forging strategic partnerships. Ramzy also held leadership positions at IMS Health, IQVIA, Microsoft-Cisco JV, Roper Technologies and CBORD. Claritev has also entered into a strategic relationship with Halian, a global provider of workforce and technology solutions. Halian will manage Claritev's payroll, recruitment, visa processing and human capital administration in the UAE, enabling the company to scale efficiently and maintain operational excellence and compliance. With over 25 years of experience delivering digital expertise across Europe and the Middle East, Halian and its expert staffing solutions will help identify professionals who will power innovation and accelerate Claritev's digital transformation goals internationally while enabling The Turn for Claritev in its continuing drive to deliver its Vision 2030 goals. 'This is a pivotal moment for Claritev as we deepen our investment in the MENA region,' said Travis Dalton, Chairman, CEO and President of Claritev. 'Ramzy's proven leadership and deep understanding of the regional healthcare landscape will be instrumental in driving our strategy forward. With Halian as our operational partner, we're well-positioned to scale efficiently and deliver meaningful impact to healthcare systems across the region.' Claritev's growing presence in the UAE underscores its mission to improve healthcare affordability, transparency and outcomes through technology-driven solutions and strategic collaborations. About Claritev Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency and optimizes networks and benefits design in healthcare. By developing purpose-build solutions that support all key stakeholders – including payors, employers, patients, providers, and third parties – Claritev is dedicated to making healthcare more accessible and affordable for all. Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit About Halian Halian has over 25 years of experience transforming IT and technology-driven businesses by connecting them with world-class talent. With a global reach and a personalized approach, Halian specializes in sourcing and placing top professionals across Cyber Security, Infrastructure, Software Engineering, Next-Gen, and Digital domains. By bridging the gap between skilled candidates and the companies that need them, Halian enables clients to unlock their full potential faster and more efficiently. Its experienced consultants work closely with organizations to deliver tailored recruitment solutions that accelerate growth and innovation. For more information, visit Media Relations Pamela Walker VP, Corporate Marketing Claritev press@ Investor Relations Jason Wong SVP, Treasury & Investor Relations Claritev investor@ Shawna Gasik AVP, Investor Relations Claritev investor@
Business Insider
29-05-2025
- Business
- Business Insider
Claritev upgraded to Overweight from Neutral at Piper Sandler
Piper Sandler analyst Jessica Tassan upgraded Claritev (CTEV) to Overweight from Neutral with a price target of $44, up from $19. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
